申请人:Gencia Corporation
公开号:US20150005258A1
公开(公告)日:2015-01-01
The invention discloses creatine derivatives that are represented by Formula (I), Formula (II), and Formula (III); wherein Z is a functional group; Y is a mitochondrial targeting agent, a cationic ammonium group, or a polypeptide containing at least one positively charged amino acid residue; each R
1
is independently hydrogen, alkyl, or a phosphate group; R
2
a linker; R
3
is a spacer group; R
4
is hydrogen, alkyl, aryl, or heterocyclic; or R
4
and R
1
, or R
4
and R
3
, together with the nitrogen atoms to which they are attached form a heterocyclic ring, and W is hydrogen or alkyl.
本发明公开了由式(I)、式(II)和式(III)表示的肌酸衍生物;其中Z是功能基团;Y是线粒体定位剂、阳离子铵基团或至少含有一个带正电氨基酸残基的多肽;每个R1独立地是氢、烷基或磷酸基团;R2是连接基;R3是间隔基团;R4是氢、烷基、芳基或杂环基;或者R4和R1,或者R4和R3,与它们连接的氮原子共同形成杂环环,W是氢或烷基。